Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.
Subscribe today for full access
to all of these articles.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.
A hot trend in capital raising for the health care and life sciences only two years ago, SPAC deals have petered out, but are far from dead.
Thermo Fisher, Helix, and Rosalind collaborate on an NIH-supported project to develop a new genotyping method to ID virus variants faster.